Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)

• Status: Recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Smoking is a significant cause of damage to health and quality of life specifically for Veterans with human immunodeficiency virus (HIV). Smoking cessation interventions for this population are lacking. The primary aim of this project is to explore smoking cessation treatment preferences among Veteran smokers living with HIV. The study team will refine the design and content of a smoking cessation treatment for Veteran smokers living with HIV. The intervention uses mobile health and telehealth technology to personalize smoking cessation counseling and medications and provide relapse prevention text messaging.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: VA Office of Research and Development
• Treatments: Bupropion; Nicotine; Varenicline

Criteria

Inclusion Criteria:

• VHA patient

• HIV positive serostatus

• currently smoking 7 cigarettes per week

• willing to complete study procedures. Exclusion criteria are:

Exclusion Criteria:

• current hospitalization

• acute risk for suicide documented in the medical record

• inability to complete study procedures.